CA2110019C - Immunodetection de la vitamine b12, reactifs et trousses - Google Patents

Immunodetection de la vitamine b12, reactifs et trousses Download PDF

Info

Publication number: CA2110019C
Authority: CA; Canada
Prior art keywords: vitamin; intrinsic factor; antibody; binding; sample
Prior art date: 1993-05-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 2110019

Other languages

English (en)

Other versions

CA2110019A1 (fr

Inventor

Karel Newman

Jane Schmidt

Paul Wegfahrt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

DIAGNOSTICS PASTEUR

Original Assignee

DIAGNOSTICS PASTEUR

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-28

Filing date

1993-11-25

Publication date

2006-01-24

1993-05-28 Priority claimed from US08/070,099 external-priority patent/US6942977B1/en

1993-11-25 Application filed by DIAGNOSTICS PASTEUR filed Critical DIAGNOSTICS PASTEUR

1994-11-29 Publication of CA2110019A1 publication Critical patent/CA2110019A1/fr

2006-01-24 Application granted granted Critical

2006-01-24 Publication of CA2110019C publication Critical patent/CA2110019C/fr

2013-11-25 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000003018 immunoassay Methods 0.000 title abstract description 16
239000003153 chemical reaction reagent Substances 0.000 title description 11
RMRCNWBMXRMIRW-WYVZQNDMSA-L vitamin b12 Chemical compound N([C@@H]([C@@]1(C)[C@@](C)(CC(N)=O)[C@H](CCC(N)=O)\C(N1[Co+]C#N)=C(/C)\C1=N\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NCC(C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO RMRCNWBMXRMIRW-WYVZQNDMSA-L 0.000 title 1
229940029329 intrinsic factor Drugs 0.000 claims abstract description 154
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 77
229930003779 Vitamin B12 Natural products 0.000 claims abstract description 74
239000011715 vitamin B12 Substances 0.000 claims abstract description 74
235000019163 vitamin B12 Nutrition 0.000 claims abstract description 74
230000027455 binding Effects 0.000 claims abstract description 67
238000009739 binding Methods 0.000 claims abstract description 67
238000003556 assay Methods 0.000 claims abstract description 28
238000000034 method Methods 0.000 claims abstract description 26
230000002860 competitive effect Effects 0.000 claims description 35
FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 27
230000003281 allosteric effect Effects 0.000 claims description 26
229940045999 vitamin b 12 Drugs 0.000 claims description 26
210000004027 cell Anatomy 0.000 claims description 19
210000004408 hybridoma Anatomy 0.000 claims description 13
102000004190 Enzymes Human genes 0.000 claims description 10
108090000790 Enzymes Proteins 0.000 claims description 10
239000007790 solid phase Substances 0.000 claims description 9
239000006228 supernatant Substances 0.000 claims description 9
102000002260 Alkaline Phosphatase Human genes 0.000 claims description 8
108020004774 Alkaline Phosphatase Proteins 0.000 claims description 8
229920002307 Dextran Polymers 0.000 claims description 8
239000003610 charcoal Substances 0.000 claims description 6
239000000203 mixture Substances 0.000 claims description 6
239000000758 substrate Substances 0.000 claims description 6
229940088594 vitamin Drugs 0.000 claims description 6
229930003231 vitamin Natural products 0.000 claims description 6
235000013343 vitamin Nutrition 0.000 claims description 6
239000011782 vitamin Substances 0.000 claims description 6
150000003722 vitamin derivatives Chemical class 0.000 claims description 6
239000012228 culture supernatant Substances 0.000 claims description 5
241001465754 Metazoa Species 0.000 claims description 4
208000007452 Plasmacytoma Diseases 0.000 claims description 3
108060003951 Immunoglobulin Proteins 0.000 claims description 2
230000003053 immunization Effects 0.000 claims description 2
102000018358 immunoglobulin Human genes 0.000 claims description 2
239000007788 liquid Substances 0.000 claims description 2
210000004698 lymphocyte Anatomy 0.000 claims 2
230000003393 splenic effect Effects 0.000 claims 2
239000003085 diluting agent Substances 0.000 claims 1
238000000605 extraction Methods 0.000 claims 1
238000011161 development Methods 0.000 abstract description 3
238000010494 dissociation reaction Methods 0.000 description 12
230000005593 dissociations Effects 0.000 description 12
102000011409 Transcobalamins Human genes 0.000 description 8
108010023603 Transcobalamins Proteins 0.000 description 8
239000000872 buffer Substances 0.000 description 7
238000006243 chemical reaction Methods 0.000 description 7
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
239000002953 phosphate buffered saline Substances 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
239000007787 solid Substances 0.000 description 7
239000011521 glass Substances 0.000 description 6
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
239000007983 Tris buffer Substances 0.000 description 5
230000003993 interaction Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
101000658547 Escherichia coli (strain K12) Type I restriction enzyme EcoKI endonuclease subunit Proteins 0.000 description 4
101000658543 Escherichia coli Type I restriction enzyme EcoAI endonuclease subunit Proteins 0.000 description 4
101000658546 Escherichia coli Type I restriction enzyme EcoEI endonuclease subunit Proteins 0.000 description 4
101000658530 Escherichia coli Type I restriction enzyme EcoR124II endonuclease subunit Proteins 0.000 description 4
101000658540 Escherichia coli Type I restriction enzyme EcoprrI endonuclease subunit Proteins 0.000 description 4
101000658545 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Type I restriction enyme HindI endonuclease subunit Proteins 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
101000658548 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaIXP endonuclease subunit Proteins 0.000 description 4
101000658542 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaVIIIP endonuclease subunit Proteins 0.000 description 4
101000658529 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaVIIP endonuclease subunit Proteins 0.000 description 4
101001042773 Staphylococcus aureus (strain COL) Type I restriction enzyme SauCOLORF180P endonuclease subunit Proteins 0.000 description 4
101000838760 Staphylococcus aureus (strain MRSA252) Type I restriction enzyme SauMRSORF196P endonuclease subunit Proteins 0.000 description 4
101000838761 Staphylococcus aureus (strain MSSA476) Type I restriction enzyme SauMSSORF170P endonuclease subunit Proteins 0.000 description 4
101000838758 Staphylococcus aureus (strain MW2) Type I restriction enzyme SauMW2ORF169P endonuclease subunit Proteins 0.000 description 4
101001042566 Staphylococcus aureus (strain Mu50 / ATCC 700699) Type I restriction enzyme SauMu50ORF195P endonuclease subunit Proteins 0.000 description 4
101000838763 Staphylococcus aureus (strain N315) Type I restriction enzyme SauN315I endonuclease subunit Proteins 0.000 description 4
101000838759 Staphylococcus epidermidis (strain ATCC 35984 / RP62A) Type I restriction enzyme SepRPIP endonuclease subunit Proteins 0.000 description 4
101000838756 Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) Type I restriction enzyme SsaAORF53P endonuclease subunit Proteins 0.000 description 4
238000002835 absorbance Methods 0.000 description 4
230000008859 change Effects 0.000 description 4
238000002523 gelfiltration Methods 0.000 description 4
238000011534 incubation Methods 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
239000002245 particle Substances 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
229920006395 saturated elastomer Polymers 0.000 description 4
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 4
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
229940098773 bovine serum albumin Drugs 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
229940112206 intrinsic factor / vitamin b 12 Drugs 0.000 description 3
230000005291 magnetic effect Effects 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
230000009257 reactivity Effects 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
210000000952 spleen Anatomy 0.000 description 3
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
241000283707 Capra Species 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
NRFJZTXWLKPZAV-UHFFFAOYSA-N N-(2-oxo-3-thiolanyl)acetamide Chemical compound CC(=O)NC1CCSC1=O NRFJZTXWLKPZAV-UHFFFAOYSA-N 0.000 description 2
208000031845 Pernicious anaemia Diseases 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
239000012506 Sephacryl® Substances 0.000 description 2
229920005654 Sephadex Polymers 0.000 description 2
239000012507 Sephadex™ Substances 0.000 description 2
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
239000012491 analyte Substances 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
229960004753 citiolone Drugs 0.000 description 2
238000012875 competitive assay Methods 0.000 description 2
230000000536 complexating effect Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000003636 conditioned culture medium Substances 0.000 description 2
230000021615 conjugation Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
108010060102 intrinsic factor receptor Proteins 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
239000006249 magnetic particle Substances 0.000 description 2
125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 2
239000002184 metal Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
-1 organometallic corrin nucleus Chemical class 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
230000028327 secretion Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
238000001542 size-exclusion chromatography Methods 0.000 description 2
210000004988 splenocyte Anatomy 0.000 description 2
230000002269 spontaneous effect Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
150000003573 thiols Chemical class 0.000 description 2
239000003656 tris buffered saline Substances 0.000 description 2
FPKVOQKZMBDBKP-UHFFFAOYSA-N 1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 FPKVOQKZMBDBKP-UHFFFAOYSA-N 0.000 description 1
IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
238000011725 BALB/c mouse Methods 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
238000009007 Diagnostic Kit Methods 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
101000999325 Homo sapiens Cobalamin binding intrinsic factor Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
229930003270 Vitamin B Natural products 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
238000010171 animal model Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
238000002820 assay format Methods 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000005388 borosilicate glass Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
125000002843 carboxylic acid group Chemical group 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
239000013626 chemical specie Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
150000001867 cobalamins Chemical class 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
229910001429 cobalt ion Inorganic materials 0.000 description 1
XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
XQRJFEVDQXEIAX-JFYQDRLCSA-M cobinamide Chemical compound [Co]N([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](O)C)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O XQRJFEVDQXEIAX-JFYQDRLCSA-M 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
230000003750 conditioning effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
WUPRCGRRQUZFAB-DEGKJRJSSA-N corrin Chemical group N1C2CC\C1=C\C(CC/1)=N\C\1=C/C(CC\1)=N/C/1=C\C1=NC2CC1 WUPRCGRRQUZFAB-DEGKJRJSSA-N 0.000 description 1
150000004038 corrins Chemical class 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000003574 free electron Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
238000009434 installation Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
235000020030 perry Nutrition 0.000 description 1
238000007747 plating Methods 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
238000011533 pre-incubation Methods 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000006916 protein interaction Effects 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
238000010187 selection method Methods 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
230000003068 static effect Effects 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
235000019156 vitamin B Nutrition 0.000 description 1
239000011720 vitamin B Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1

Landscapes

Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

CA 2110019 1993-05-28 1993-11-25 Immunodetection de la vitamine b12, reactifs et trousses Expired - Fee Related CA2110019C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US070,099		1993-05-28
US08/070,099 US6942977B1 (en)	1991-04-09	1993-05-28	Immunoassays for determining vitamin b12, and reagents and kits therefor

Publications (2)

Publication Number	Publication Date
CA2110019A1 CA2110019A1 (fr)	1994-11-29
CA2110019C true CA2110019C (fr)	2006-01-24

Family

ID=22093115

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2110019 Expired - Fee Related CA2110019C (fr)	1993-05-28	1993-11-25	Immunodetection de la vitamine b12, reactifs et trousses

Country Status (2)

Country	Link
JP (1)	JP3433245B2 (fr)
CA (1)	CA2110019C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2023239935A1 (fr) *	2022-06-10	2023-12-14	Xeragenx Llc	Détection du facteur intrinsèque (if) gastrique dans des échantillons de fluide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050158812A1 (en) *	2004-01-16	2005-07-21	Gomez Elizabeth A.	Kits and methods for autoantibody detection

1993
- 1993-11-25 CA CA 2110019 patent/CA2110019C/fr not_active Expired - Fee Related
1994
- 1994-05-27 JP JP13823094A patent/JP3433245B2/ja not_active Expired - Fee Related

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2023239935A1 (fr) *	2022-06-10	2023-12-14	Xeragenx Llc	Détection du facteur intrinsèque (if) gastrique dans des échantillons de fluide

Also Published As

Publication number	Publication date
JP3433245B2 (ja)	2003-08-04
JPH0712811A (ja)	1995-01-17
CA2110019A1 (fr)	1994-11-29

Publication	Publication Date	Title
US4536479A (en)	1985-08-20	Use of anti-idiotype antibodies in immunoassays
US4469787A (en)	1984-09-04	Immunoassay involving soluble complex of second antibody and labeled binding protein
US5223441A (en)	1993-06-29	Receptors for immune complexes
EP0166623A2 (fr)	1986-01-02	Test-sandwich à anticorps lectine
CA2008360A1 (fr)	1990-07-23	Essai immunologique pour le diagnostic de l'infarctus du myocarde
US4513088A (en)	1985-04-23	Assay for monoclonal antibody against surface Ig of a human B cell tumor
EP0475783B1 (fr)	1999-12-01	Anticorps contre les ligand-analogues et leur usage dans les dosages ligand-recepteurs
US4665018A (en)	1987-05-12	Methods and test kit for diagnosing/monitoring cancer in humans
CA2008304C (fr)	2001-03-27	Dosage de la phosphatase alcaline des os
US6942977B1 (en)	2005-09-13	Immunoassays for determining vitamin b12, and reagents and kits therefor
JPH01262471A (ja)	1989-10-19	Ｃｋｍｂ検定及びそれに使用するモノクローナル抗体
US6201109B1 (en)	2001-03-13	Assay for bone alkaline phosphatase
CA2110019C (fr)	2006-01-24	Immunodetection de la vitamine b12, reactifs et trousses
KR100375564B1 (ko)	2003-05-12	N-펩티드의샌드위치면역학적측정법
US5620861A (en)	1997-04-15	Method and kit for pyridinium crosslink assay
EP0653067B1 (fr)	2003-01-22	Procede et materiel de reticulation en presence d'ions pyridium
EP0554458B1 (fr)	1999-03-24	Dosage immunologique et anticorps monoclonal pour la detection de toxines diarrheiques des dinoflagelles
US4929544A (en)	1990-05-29	Reagents, methods, and test kit for diagnosing/monitoring cancer in humans
CA2281262C (fr)	2010-08-31	Anticorps monoclonal anti-medullasine humaine, processus de production et dosage immunologique utilisant cet anticorps moinoclonal
US7833726B2 (en)	2010-11-16	Antibody for assaying ADAMTS13 activity and method for assaying the activity
EP0133540A1 (fr)	1985-02-27	Déterminations d'un récepteur employant des anticorps marqués monoclonaux et anti-idiotypiques
US5736344A (en)	1998-04-07	Serum pyridinium crosslinks assay
JP3448295B2 (ja)	2003-09-22	血清ピリジニウム架橋物アッセイ
CA2355893C (fr)	2010-02-02	Anticorps monoclonal anti-uracil
JP3569074B2 (ja)	2004-09-22	イムノアッセイ法

Legal Events

Date	Code	Title	Description
2000-11-21	EEER	Examination request
2007-11-26	MKLA	Lapsed

CA2110019C - Immunodetection de la vitamine b12, reactifs et trousses - Google Patents

Info

Links

Landscapes

Applications Claiming Priority (2)

Publications (2)

Family

ID=22093115

Family Applications (1)

Country Status (2)

Cited By (1)

Families Citing this family (1)

Cited By (1)

Also Published As

Similar Documents

Legal Events